# ğŸ§¬ Integration of Clinical and Molecular Factors in the Risk Assessment for Gestational Diabetes Mellitus


![Python](https://img.shields.io/badge/Python-3.12-blue.svg?logo=python&logoColor=white)
![R](https://img.shields.io/badge/R-4.5-blue.svg?logo=r&logoColor=white)
![RNA-Seq](https://img.shields.io/badge/Bioinformatics-RNA--Seq-green.svg)
![Logistic Regression](https://img.shields.io/badge/Statistics-Logistic%20Regression-orange.svg)

---
â— *The data presented here are preliminary results from an ongoing study. A manuscript is currently being prepared for publication in a scientific journal.*

---
## ğŸ“– Summary
This research investigates the potential of integrating **clinical data with placental transcriptomics** to improve risk assessment for Gestational Diabetes Mellitus (GDM).  

- Traditional clinical factors remain strong predictors.  
- Placental molecular signatures reveal new biological insights.  
- The integrated model shows improved predictive performance.  

---

## â“ Problem
GDM is a **multifactorial metabolic disorder** posing risks to both mother and fetus.  

- Diagnosis relies on the **OGTT**, which has limitations.  
- Clinical factors like pre-gestational **BMI** capture only part of the risk.  
- **Placenta** plays a crucial role in maternal metabolic adaptation, but is underexplored in risk models.  

This study addresses whether combining **placental molecular data** with **clinical parameters** yields a more robust model.

---

## ğŸ§ª Methodology

**Dataset**: GEO repository, 41 pregnant women (21 GDM, 20 controls).  

- ğŸ©º **Clinical Data**: Python (Pandas, Statsmodels). Missing values handled by MICE. BMI calculated and categorized.  
- ğŸ”¬ **Transcriptomics**: Bulk RNA-seq pipeline â†’ filtering, log2(CPM+1), Z-score scaling, PCA.  
- ğŸ¯ **DEG Analysis**: limma (R via rpy2 in Python), with voom transformation.  
- ğŸ“Š **Enrichment Analysis**: GSEA using Gseapy.  
- ğŸ“ˆ **Modeling**: Logistic Regression (Statsmodels), with VIF & Pearson for multicollinearity, and simulated envelopes for fit.  
- ğŸ§¾ **Transcriptomic Score**: CSH1 + CSH2 Z-scores combined.  

---

## ğŸ’» Skills

- ğŸ **Python (v3.12.3)** â†’ Pandas, Numpy, Statsmodels, Scikit-learn, SciPy, Gseapy, Matplotlib, Seaborn, rpy2  
- ğŸ“Š **R (v4.5.1)** â†’ limma-voom, hnp  
- ğŸ“ˆ **Statistics** â†’ Logistic Regression, MICE, VIF, Half-Normal Plots  
- ğŸ”¬ **Bioinformatics** â†’ RNA-seq, DEG, GSEA  

---

## ğŸ“Š Results

### Clinical Analysis

##### Group Characterization

<p align="center">
  <img src="oGTT.png" width="25%">
  <img src="images/BMI.png" width="25%">
  <img src="catBMI.png" width="40%">
</p>


##### Logistic Regression Results

<p align="center">
  <img src="Modelo_clin.png" width="50%" alt="Integrated Model">
</p>

<p align="center">
  <img src="Mod_cli_or.png" width="80%" alt="Odds Ratios">
</p>


> The logistic regression model was well fitted and statistically significant.  
> For each **1-unit increase in BMI**, the odds of developing GDM increased by **1.39** (OR = 1.39). For each **1 mmol/L increase in 1-hour glycemia**, the odds increased by **3.21** (OR = 3.21).



### Transcriptomic Analysis
From placentas of patients diagnosed with gestational diabetes or from control subjects.


> A distinct molecular signature of *â€œresponse to nutrient levelsâ€ (GO:0031667)* was identified in the placentas of women with GDM.  
> This was characterized by the significant upregulation of genes from the **Chorionic Somatomammotropin Hormone (CSH) group**, responsible for producing **placental lactogen (PL)**.



| PCA | GSEA 
|-----|------|
| <img src="PCA.png" width="70%"> | <img src="images/GSEA.jpg" width="100%"> 

| CSH Expression|
|---|
| <img src="heatmap_exp.png" width="50%"> |



##### Integrated Model


>Although the CSH gene score was not statistically significant on its own (p = 0.074), including it in the clinical model led to a **better overall fit**, as shown by a lower AIC (36.85 vs. 39.00). Moreover, it increased the effect size of the clinical predictors, with the odds ratio (OR) for Glycemia rising to 3.97 and for BMI to 1.49.

<p align="center">
  <img src="mod_gene.png" width="50%" alt="Integrated Model">
</p>

<p align="center">
  <img src="mod_gen_OR.bmp" width="80%" alt="Odds Ratios">
</p>


---

## ğŸ“ Conclusion
- Clinical risk factors (**BMI, glycemia**) remain strong predictors of GDM.  
- **Placental lactogen signature (CSH genes)** adds biological depth and improves model fit.  
- This suggests **placental lactogen** could serve as a **biomarker** for better GDM diagnosis and management.  

---

## ğŸ”® Next Steps
- ğŸ“ˆ **Validation** â†’ Larger, more diverse cohorts.  
- ğŸ• **Prospective Studies** â†’ Test early pregnancy predictive value.  
- ğŸ§ª **Serum Biomarker Development** â†’ Translate placental transcriptomic signature into non-invasive clinical tools.  

---


